Sweep 2.2 Flashcards
Candidosis-
Reduced host defense {immunosuppressed individuals, infant and adult who has been on antibiotic therapy for some time}
C.albicans is frequently isolated from the subgingival flora of patients with severe periodontitis.
Candidosis-
lesions
Painless or slightly sensitive
Red and white lesions
Lesions can be scraped or separated from mucosa
Cancer patients receiving high dose radiation or
chemotherapy
Patients who are using several different antibiotics
over a period of several weeks or months
Diabetic patients
Women who develop vaginal candidiasis
Pregnancy and the use of contraceptives
Most clinical charateristic of gingival candidal infections is
redness of the attached gingiva, often associated with granular surface.
Different types or oral mucosal manifestations:
Pseudomembraneous (whitish patches that can be wiped off)
Erythematous (red, associated with pain)
Plaque type (whitish plaque that cannot be removed; need to differentiate from oral leukoplakia)
Nodular (slightly elevated nodules of white or reddish color)
Linear gingival erythema-
- Distinct linear erythematous band limited to the free gingiva.
- Lack of bleeding.
Positive for C.albicans by culture:
50% of HIV associated gingivitis sites,
26% of unaffected sites of HIV seropositive patients, 3% of healthy sites of HIV negative patients.
LGE: Linear gingival erythema-
- Gingival manifestation of
immunosuppression
characterized by a distinct linear erythematous band
limited to the free gingiva
LGE:
- Does not respond well to
improved oral hygiene or to scaling.
LGE: - A disproportion between
inflammation and plaque accumulation.
LGE: Treatment:
- Conventional therapy plus chlorhexidine 0.12% rinse
- Antimycotic therapy if Candida is detected.
Histoplasmosis-
- Granulomatous disease caused by Histoplasma capsulatum *
- Acute and chronic pulmonary histoplasmosis and a disseminated form… Immunocompromised patients.
- Any area of the oral mucosa (mainly tongue).
- Nodular or papillary and later may become ulcerative type of lesions with pain.
Diagnosis: Clinical view and histopathology, systemic manifestations
Treatment: Systemic antifungal therapy
Hereditary gingival fibromatosis-
Possible mechanism(s):
TGF-1 favor the accumulation of ECM.
May be located on chromosome 2 in human.
[ Defect in the Son of Sevenless-1 gene on chromosome 2p21-p22]
LAP: Most frequently between
puberty & 20yrs of age.
LAP: Pattern:
Localized CAL in first molars/incisors (at least 1 first molar must be affected).
LAP: Distribution: no more than
2 teeth other than first molars and incisors are affected .
CAL is inconsistent with amount of plaque & calculus.
LAP: Relatively less intense
gingival inflammation.
LAP: Robust
serum antibody response (IgG2).
Self limiting
GAP: Distribution: AT least 3 permanent teeth other than
1st molars & incisors.
GAP: Pronounced episodic nature of the
destruction of attachment/bone.
gAP: Relatively intense
gingival inflammation.
Poor serum antibody response.
A.a is associated with
LAP - particularly JP2 clone serotype
A.a
Facultative anaerobe, nonmotile.
A.a can
translocate across JE, invade CT
A.a Virulence factors:
Leukotoxins: kills PMNs and MΦ LPS: activates cells to produce PGs, IL-1, TNF- Collagenases: degrades collagen fibers Immunosuppressive factors : Lymphocyte supprressing factors Chemotactic suppressing factors